FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES

MDR report key: 16348677 · Received February 10, 2023

Report

Report Number
9617032-2023-00161
Event Type
Malfunction
Date Received
February 10, 2023
Date of Event
January 30, 2023
Report Date
August 2, 2023
Manufacturer
BECTON, DICKINSON AND COMPANY (BD)
Product Code
JKA
UDI-DI
50382903679558
PMA / PMN Number
BK050036
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH ADDITIONAL INFORMATION: B.5. DESCRIBE EVENT OR PROBLEM: IT WAS REPORTED THAT 2 LOTS OF BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES HAD GEL SMEARING ON SIDES OF TUBE AND ERRONEOUS RESULTS WERE OBTAINED. THERE WAS NO REPORT OF CONFIRMATORY TESTING OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE RECEIVED EMAIL FROM OUR DEPT OF LAB MEDICINE (DLM), THAT WE HAVE ENCOUNTERED SOME ANALYTICAL ISSUES ON MONDAY ¿ 30 JAN 2023, AND OUR DLM FOUND THAT THE AFFECTED SAMPLE TUBES HAD SOME GELATINOUS SUBSTANCE ON THE SIDES OF THE TUBES. H.6 ADDITIONAL IMDRF ANNEX A CODE: A0908.

Additional Manufacturer Narrative · 0

THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 2112278. MEDICAL DEVICE EXPIRATION DATE: 31-OCT-2023. DEVICE MANUFACTURE DATE: 22-APR-2022. MEDICAL DEVICE LOT #: 2126976. MEDICAL DEVICE EXPIRATION DATE: 30-NOV-2023. DEVICE MANUFACTURE DATE: 06-MAY-2022. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: BD HAD NOT RECEIVED SAMPLES, BUT 1 PHOTO WAS PROVIDED FOR INVESTIGATION. THE PHOTO WAS REVIEWED AND THE INDICATED FAILURE MODE FOR GEL SMEARING WAS NOT OBSERVED; PHOTO WAS UNCLEAR. ERRONEOUS RESULTS CANNOT BE EVALUATED THROUGH PHOTOS, CLINICAL TESTING WAS PERFORMED. RETENTION SAMPLES OF THE INCIDENT LOT WERE SELECTED FROM BD INVENTORY FOR CLINICAL EVALUATION AND UPON COMPLETION, NO ISSUES RELATING TO ERRONEOUS RESULTS OR GEL SMEARING WAS OBSERVED: THERE WERE NO DIFFICULTIES ENCOUNTERED DURING BLOOD COLLECTION AND ALL TUBES EXHIBITED PROPER FILL. BD WAS UNABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE MODES (GEL SMEARING AND ERRONEOUS RESULTS-CREATININE KINASE) VIA CLINICAL INVESTIGATION BECAUSE THE DEFECT WAS NOT EVIDENT IN THE TESTING OF THE COMPLAINT LOT SAMPLES. ALL VISUAL OBSERVATIONS OF BOTH RETENTION AND CONTROL SAMPLES TESTED DEMONSTRATED CLINICALLY ACCEPTABLE PERFORMANCE. REPLICATES OF BOTH RETENTION AND CONTROL SAMPLES WERE ACCEPTABLE IN TERMS OF BOTH PRECISION AND ACCURACY. BASED ON A REVIEW OF THE DEVICE HISTORY RECORD FOR THE INCIDENT LOT, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET. THERE WERE NO RELATED QUALITY ISSUES DURING MANUFACTURING OF THE PRODUCT. THIS COMPLAINT IS UNABLE TO BE CONFIRMED FOR GEL SMEARING AND ERRONEOUS RESULTS. BD WAS NOT ABLE TO IDENTIFY A ROOT CAUSE FOR THE INDICATED FAILURE MODES. FACTORS THAT MAY CONTRIBUTE TO GEL SMEARING AND ERRONEOUS RESULTS WERE EVALUATED THROUGH A CLINICAL STUDY TO VERIFY THE DESIGN OF THE DEVICE MET IT¿S INTENDED USE. THE RESULT OF THE STUDY SHOWED THAT THE DEVICE PERFORMED AS EXPECTED AND WE WERE UNABLE TO DETERMINE ANY EXTERNAL CONTRIBUTOR TO THIS REPORTED ISSUE. H3 OTHER TEXT : SEE H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2 LOTS OF BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES HAD GEL SMEARING ON SIDES OF TUBE AND ERRONEOUS RESULTS WERE OBTAINED. THERE WAS NO REPORT OF CONFIRMATORY TESTING OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE RECEIVED EMAIL FROM OUR DEPT OF LAB MEDICINE (DLM), THAT WE HAVE ENCOUNTERED SOME ANALYTICAL ISSUES ON MONDAY ¿ 30 JAN 2023, AND OUR DLM FOUND THAT THE AFFECTED SAMPLE TUBES HAD SOME GELATINOUS SUBSTANCE ON THE SIDES OF THE TUBES.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2 LOTS OF BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES HAD GEL SMEARING ON SIDES OF TUBE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE RECEIVED EMAIL FROM OUR DEPT OF LAB MEDICINE (DLM), THAT WE HAVE ENCOUNTERED SOME ANALYTICAL ISSUES ON MONDAY ¿ (B)(6) 2023 AND OUR DLM FOUND THAT THE AFFECTED SAMPLE TUBES HAD SOME GELATINOUS SUBSTANCE ON THE SIDES OF THE TUBES.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2 LOTS OF BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES HAD GEL SMEARING ON SIDES OF TUBE AND ERRONEOUS RESULTS WERE OBTAINED. THERE WAS NO REPORT OF CONFIRMATORY TESTING OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE RECEIVED EMAIL FROM OUR DEPT OF LAB MEDICINE (DLM), THAT WE HAVE ENCOUNTERED SOME ANALYTICAL ISSUES ON MONDAY ¿ 30 JAN 2023, AND OUR DLM FOUND THAT THE AFFECTED SAMPLE TUBES HAD SOME GELATINOUS SUBSTANCE ON THE SIDES OF THE TUBES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
54342 BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES BLOOD SPECIMEN COLLECTION DEVICE JKA BECTON, DICKINSON AND COMPANY (BD) 367955 SEE H.10 50382903679558

Patients

Seq Age Sex Outcome Treatment
1 Unknown